Ancora Advisors’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Ancora Advisors’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500	Closed	-$170	–	1947
2024 Q1	$170	Hold	500	–	–	﹤0.01%	1743
2023 Q4	$100	Sell	500 -19,674	-98%	-$4.11K	﹤0.01%	1694
2023 Q3	$3.33K	Hold	20,174	–	–	﹤0.01%	1442
2023 Q2	$2.71K	Hold	20,174	–	–	﹤0.01%	1459
2023 Q1	$1.01K	Sell	20,174 -10	-0%	-$1	﹤0.01%	1625
2022 Q4	$1K	Sell	20,184 -10,000	-33%	-$818	﹤0.01%	1725
2022 Q3	$2K	Hold	30,184	–	–	﹤0.01%	1832
2022 Q2	$8K	Hold	30,184	–	–	﹤0.01%	1672
2022 Q1	$12K	Buy	30,184 +500	+2%	+$228	﹤0.01%	1690
2021 Q4	$20K	Hold	29,684	–	–	﹤0.01%	1593
2021 Q3	$20K	Buy	29,684 +400	+1%	+$320	﹤0.01%	1484
2021 Q2	$27K	Buy	+29,284	New	+$23.4K	﹤0.01%	1270

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Ancora Advisors's AONCW Position: Q2 2024 in Review

Ancora Advisors sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 500 shares — an estimated $170 sold.

Ancora Advisors first reported a position in AONCW in Q2 2021 and held it in 12 quarters. The position peaked at $27K in Q2 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Ancora Advisors reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Ancora Advisors sold 500 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $170.
Ancora Advisors first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 12 quarters.
Ancora Advisors's American Oncology Network, Inc. Warrant position peaked at $27K in Q2 2021.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Ancora Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.